An automated multiplexed bioreactor platform for optimization of mammalian processes
[Fileref]:
PR22-003
II.1.2)
[CpvMain]
38970000
-
II.1.3)
[TypeContract]
[Supplies]
II.1.4)
[DescrShort]
NIBRT is looking to procure an automated multiplexed bioreactor platform for optimisation of mammalian cell processes to produce monoclonal antibodies, recombinant proteins, and viral vectors for gene therapy applications.
[Section6]: [InfoComplement]
VI.6)
[IcarOriginalRef]
[NumberOj]: 2022/S 071-188784
[Section7]: [Changes]
VII.1)
[IcarCorrectAdd]
VII.1.2)
[IcarTextCorrected]
[SectionNo]:
IV.2.2)
[IcarTextCorrPlace]:
Time limit for receipt of tenders or requests to participate